The American Academy of Pain Medicine      Annual Meeting Home Page     
23rd Annual Meeting
February 7-10, 2007
New Orleans, LA

© 2006 American Academy of Pain Medicine
 


Thursday, February 8, 2007
104

Pain as a Reason for Seeking Admission to Methadone Treatment

J. David Haddox, DDS, MD1, Meredith Smith, MPA, PhD1, Salvatore Colucci1, Andrew Rosenblum, PhD2, Chunki Fong, MS2, Carleen Maxwell, MPH3, and Mark Parrino, MPA3. (1) Purdue Pharma L.P., Stamford, CT, USA, (2) National Development and Research Institutes (NDRI), New York, NY, USA, (3) American Association for the Treatment of Opioid Dependence (AATOD), New York, NY, USA

Introduction: Pain is a common comorbidity among patients in substance abuse treatment. This study sought to assess the extent to which pain was endorsed as a reason for seeking admission to methadone maintenance. Methods: Cross-sectional survey of 5,803 individuals admitted to 69 US methadone maintenance treatment programs (MMTPs) between 1/05 -09/05. Respondents completed a structured, self-administered, 1 page questionnaire at intake. Pain (Non-withdrawal intensity) was measured on a 5-point scale (None – Very Severe). “Chronic pain” was defined as non-withdrawal pain of >moderate intensity and pain duration of >6 months. Generalized estimating equations (GEE) were used to examine associations between pain as a reason for enrollment and socio-demographic and drug-related variables; predictors with a p value of < 0.01 were reported. Results: 32.9% of study respondents endorsed pain as a reason for seeking enrollment in methadone maintenance. Of these, most were male (62.3%), Caucasian (65.7%) with a mean age of 37.2 years (SD ± 10.6). The primary drug of abuse within the past month was heroin (58.1%), or an opioid analgesic (41.9%). 69.3% reported experiencing severe or very severe withdrawal pain within the past week; and 63.8% reported severe or very severe bodily pain during that same period. Factors that were significant predictors of pain as a reason for enrollment in multivariate analyses included: having chronic pain (p<0.0001), being non-white (p<0.0001), being unemployed (p=0.006), methadone abuse within the past month (p=0.002), and, to have obtained their primary drug of abuse from a doctor's prescription (p=0.01). Conclusions: Methadone maintenance patients who cite pain as a reason for seeking substance abuse treatment are significantly likely to report having persistent bodily pain of moderate to severe intensity. They are also likely to have recently been abusing methadone, to be nonwhite and unemployed, and to obtain their primary drug of abuse through a prescription.

References: Liang D-Y, Guo T, Liao G, Kingery W, Peltz G, Clark JD Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence Pain. 2006;121:232-240

Kerr T Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver Drug and Alcohol Dependence. 2005;80(3):329-335

Rosenblum A Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities JAMA. 2003;289(18):2370-2378
Funding: None

J. David Haddox, DDS, MD
Nothing to disclose.